COVID-19 AND CENTRAL LINE-ASSOCIATED BLOODSTREAM INFECTION: A SINGLE TERTIARY CENTER EXPERIENCE

ABSTRACT

B Introduction/Hypothesis: b An increase in the rates of central line-associated bloodstream infections (CLABSI) during the COVID-19 pandemic has been previously described. Descriptive statistics were used to explore the relationship between COVID-19 positive (COVID+) CLABSI infections and COVID-19 negative (COVID-) CLABSI infections. The purpose of this investigation was to examine the data from institutional CLABSI infections and identify risk factors for CLABSI development in the presence of COVID-19. [Extracted from the article] Copyright of Critical Care Medicine is the property of Lippincott Williams & Wilkins and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)